Magazine Article | November 1, 2015

How Much Transparency Is Too Much With Clinical Trials?

Source: Life Science Leader

By Sujay Jadhav, CEO, goBalto

There is a growing movement by some researchers and regulators to increase disclosure of clinical trial results. According to advocates, the push for greater transparency would result in the publication of all clinical trial results, including those currently under investigation, as well as past trials conducted. In response, several pharmaceutical companies have publically embraced the concept of clinical trial transparency, notably AstraZeneca with the recent creation of a Scientific Review Board to independently assess requests for data.